Doing targeted COPD case finding as part of NHS lung cancer checks could save £33m over the next decade, research has shown.

Pulmonary arterial hypertension (PAH) is a rare condition that's difficult to treat. The hallmarks of the disease—narrowing ...

Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road ...

CheapInsurance.com reports that a new $2,000 out-of-pocket cap under Medicare Part D will save millions, but challenges ...

Arquitos Capital shares its Q3 2025 investor letter highlighting a 66.8% YTD return and value-driven strategy. Read how ...

The FDA granted approval to nerandomilast, now Jascayd, for treating adults with idiopathic pulmonary fibrosis, marking the ...

EMA approval covers study sites in Germany and Poland as part of the Company’s global Phase 2 RENEW trialTrial will evaluate ...

The Pulmonary Association's "EmPHasize Your Health" campaign highlights the importance of whole-person health by inspiring physical and emotional wellness among people navigating the challenges of ...

The mum of a one-year-old boy with a severe health condition has been told she must raise £1.5 million to afford the ...

After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...

Northwest Health – Porter has announced the appointment of Dan Doherty, as its new Chief Executive Officer, effective Oct. 27, according to a release.

Georgia Northwestern Technical College respiratory care graduate, Jay Shedd, system director of Respiratory Therapy, Sleep ...